A Single Autophosphorylation Site on KDR/Flk-1 is Essential for VEGF-A-dependent Activation of PLC-gamma and DNA Synthesis in Vascular Endothelial Cells

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2001 Jun 2

PMID 11387210

Citations 296

Authors

T Takahashi

S Yamaguchi

K Chida

M Shibuya

Affiliations

Soon will be listed here.

Abstract

KDR/Flk-1 tyrosine kinase, one of the two vascular endothelial growth factor (VEGF) receptors, induces mitogenesis and differentiation of vascular endothelial cells. To understand the mechanisms underlying the VEGF-A-induced growth signaling pathway, we constructed a series of human KDR mutants and examined their biological properties. An in vitro kinase assay and subsequent tryptic peptide mapping revealed that Y1175 and Y1214 are the two major VEGF-A-dependent autophosphorylation sites. Using an antibody highly specific to the phosphoY1175 region, we demonstrated that Y1175 is phosphorylated rapidly in vivo in primary endothelial cells. When the mutated KDRs were introduced into the endothelial cell lines by adenoviral vectors, only the Y1175F KDR, Tyr1175 to phenylalanine mutant, lost the ability to tyrosine phosphorylate phospholipase C-gamma and, significantly, reduced MAP kinase phosphorylation and DNA synthesis in response to VEGF-A. Furthermore, primary endothelial cells microinjected with anti-phosphoY1175 antibody clearly decreased DNA synthesis compared with control cells. These findings strongly suggest that autophosphorylation of Y1175 on KDR is crucial for endothelial cell proliferation, and that this region is a new target for anti-angiogenic reagents.

Citing Articles

Contribution of tumor microenvironment (TME) to tumor apoptosis, angiogenesis, metastasis, and drug resistance.

Xiao Y, Hassani M, Moghaddam M, Fazilat A, Ojarudi M, Valilo M Med Oncol. 2025; 42(4):108.

PMID: 40087196 DOI: 10.1007/s12032-025-02675-8.

Translationally Controlled Tumor Protein Enhances Angiogenesis in Ovarian Tumors by Activating Vascular Endothelial Growth Factor Receptor 2 Signaling.

Rho S, Kim B, Lee S, Lee C Biomol Ther (Seoul). 2024; 33(1):193-202.

PMID: 39664017 PMC: 11704413. DOI: 10.4062/biomolther.2024.206.

TM4SF1 is a molecular facilitator that distributes cargo proteins intracellularly in endothelial cells in support of blood vessel formation.

Lin C, Merley A, Jaminet S J Cell Commun Signal. 2024; 18(2):e12031.

PMID: 38946725 PMC: 11208120. DOI: 10.1002/ccs3.12031.

Elevated VEGF-A Levels in the Aqueous Humor of Patients With Primary Open Angle Glaucoma.

Dimtsas G, Ieronymaki A, Chatzistefanou K, Siasos G, Krassas A, Moschos M In Vivo. 2024; 38(4):1875-1881.

PMID: 38936903 PMC: 11215581. DOI: 10.21873/invivo.13642.

Muscone abrogates breast cancer progression through tumor angiogenic suppression via VEGF/PI3K/Akt/MAPK signaling pathways.

Wang D, Liu X, Hong W, Xiao T, Xu Y, Fang X Cancer Cell Int. 2024; 24(1):214.

PMID: 38898449 PMC: 11188526. DOI: 10.1186/s12935-024-03401-6.

References

Namba K, Abe M, Saito S, Satake M, Ohmoto T, Watanabe T . Indispensable role of the transcription factor PEBP2/CBF in angiogenic activity of a murine endothelial cell MSS31. Oncogene. 2000; 19(1):106-14. DOI: 10.1038/sj.onc.1203257. View

Fujio Y, Walsh K . Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem. 1999; 274(23):16349-54. PMC: 3624707. DOI: 10.1074/jbc.274.23.16349. View

Margolis B, Lax I, Kris R, Dombalagian M, Honegger A, Howk R . All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor. J Biol Chem. 1989; 264(18):10667-71. View

Ferrara N, Henzel W . Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989; 161(2):851-8. DOI: 10.1016/0006-291x(89)92678-8. View

Connolly D, Heuvelman D, Nelson R, Olander J, Eppley B, Delfino J . Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989; 84(5):1470-8. PMC: 304011. DOI: 10.1172/JCI114322. View

Leung D, Cachianes G, Kuang W, Goeddel D, Ferrara N . Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989; 246(4935):1306-9. DOI: 10.1126/science.2479986. View

Keck P, Hauser S, Krivi G, Sanzo K, Warren T, Feder J . Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 1989; 246(4935):1309-12. DOI: 10.1126/science.2479987. View

Folkman J . What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst. 1990; 82(1):4-6. DOI: 10.1093/jnci/82.1.4. View

Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H . Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 1990; 5(4):519-24. View

10.

Yanai N, Satoh T, Obinata M . Endothelial cells create a hematopoietic inductive microenvironment preferential to erythropoiesis in the mouse spleen. Cell Struct Funct. 1991; 16(1):87-93. DOI: 10.1247/csf.16.87. View

11.

Mohammadi M, Honegger A, Rotin D, Fischer R, Bellot F, Li W . A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mol Cell Biol. 1991; 11(10):5068-78. PMC: 361508. DOI: 10.1128/mcb.11.10.5068-5078.1991. View

12.

Terman B, Carrion M, Kovacs E, Rasmussen B, Eddy R, Shows T . Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene. 1991; 6(9):1677-83. View

13.

Matthews W, Jordan C, Gavin M, Jenkins N, Copeland N, Lemischka I . A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci U S A. 1991; 88(20):9026-30. PMC: 52644. DOI: 10.1073/pnas.88.20.9026. View

14.

Pepper M, Ferrara N, Orci L, Montesano R . Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun. 1991; 181(2):902-6. DOI: 10.1016/0006-291x(91)91276-i. View

15.

Rotin D, Margolis B, Mohammadi M, Daly R, Daum G, Li N . SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gamma. EMBO J. 1992; 11(2):559-67. PMC: 556487. DOI: 10.1002/j.1460-2075.1992.tb05087.x. View

16.

Ferrara N, Houck K, Jakeman L, Winer J, Leung D . The vascular endothelial growth factor family of polypeptides. J Cell Biochem. 1991; 47(3):211-8. DOI: 10.1002/jcb.240470305. View

17.

de Vries C, Escobedo J, Ueno H, Houck K, Ferrara N, Williams L . The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 1992; 255(5047):989-91. DOI: 10.1126/science.1312256. View

18.

Fantl W, Escobedo J, Martin G, Turck C, del Rosario M, McCormick F . Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell. 1992; 69(3):413-23. DOI: 10.1016/0092-8674(92)90444-h. View

19.

Sarzani R, Arnaldi G, De Pirro R, Moretti P, Schiaffino S, Rappelli A . A novel endothelial tyrosine kinase cDNA homologous to platelet-derived growth factor receptor cDNA. Biochem Biophys Res Commun. 1992; 186(2):706-14. DOI: 10.1016/0006-291x(92)90804-t. View

20.

Ronnstrand L, Mori S, Arridsson A, Eriksson A, Wernstedt C, Hellman U . Identification of two C-terminal autophosphorylation sites in the PDGF beta-receptor: involvement in the interaction with phospholipase C-gamma. EMBO J. 1992; 11(11):3911-9. PMC: 556901. DOI: 10.1002/j.1460-2075.1992.tb05484.x. View